Alcon AG (ALC)vsDaxor Corporation (DXR)
ALC
Alcon AG
$69.83
+0.59%
HEALTHCARE · Cap: $33.92B
DXR
Daxor Corporation
$8.78
-2.12%
HEALTHCARE · Cap: $56.92M
Smart Verdict
WallStSmart Research — data-driven comparison
Alcon AG generates 34633191% more annual revenue ($10.86B vs $31,360). DXR leads profitability with a 19861.0% profit margin vs 5.9%. DXR trades at a lower P/E of 8.9x. ALC earns a higher WallStSmart Score of 51/100 (C-).
ALC
Buy51
out of 100
Grade: C-
DXR
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-23.1%
Fair Value
$64.49
Current Price
$69.83
$5.34 premium
Intrinsic value data unavailable for DXR.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Keeps 19861 of every $100 in revenue as profit
Earnings expanding 329.3% YoY
Every $100 of equity generates 23 in profit
Revenue surging 25.5% year-over-year
Areas to Watch
ROE of 3.0% — below average capital efficiency
5.9% margin — thin
Premium valuation, high expectations priced in
Earnings declined 44.6%
Smaller company, higher risk/reward
Weak financial health signals
Negative free cash flow — burning cash
Operating margin of -4530.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : ALC
The strongest argument for ALC centers on Debt/Equity, Price/Book. PEG of 1.21 suggests the stock is reasonably priced for its growth.
Bull Case : DXR
The strongest argument for DXR centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 19861.0% and operating margin at -4530.0%. Revenue growth of 25.5% demonstrates continued momentum.
Bear Case : ALC
The primary concerns for ALC are Return on Equity, Profit Margin, P/E Ratio. A P/E of 53.2x leaves little room for execution misses.
Bear Case : DXR
The primary concerns for DXR are Market Cap, Piotroski F-Score, Free Cash Flow.
Key Dynamics to Monitor
ALC profiles as a value stock while DXR is a growth play — different risk/reward profiles.
ALC carries more volatility with a beta of 0.73 — expect wider price swings.
DXR is growing revenue faster at 25.5% — sustainability is the question.
ALC generates stronger free cash flow (414M), providing more financial flexibility.
Bottom Line
ALC scores higher overall (51/100 vs 49/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Alcon AG
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.
Visit Website →Daxor Corporation
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Daxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States. The company is headquartered in New York, New York.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?